NPPA notified regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer)

Mar 10, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 06, 2025, 2025, notified regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer).

It has fixed the rate at Rs. 19.01/- for each film coated tablet containing: Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer).


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT